{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 interacts with RAD23B, a key component of the ubiquitin-proteasome pathway. This interaction has been confirmed through co-immunoprecipitation experiments.",
  "functions": [
    {
      "function": "Inhibition of ATXN3 Proteasomal Degradation",
      "arrow": "activates",
      "cellular_process": "Similar to its homolog RAD23A, ATXN3 directly interacts with the proteasome shuttle protein RAD23B through its Ubiquitin-binding site 2 (UbS2). This binding event protects ATXN3 from proteasomal turnover.",
      "effect_description": "The interaction with RAD23B shields ATXN3 from degradation, thus increasing its stability and cellular protein levels. This function is considered redundant with RAD23A.",
      "biological_consequence": [
        "ATXN3 binds to RAD23B via its UbS2 domain → This interaction prevents ATXN3 from being targeted for proteasomal degradation → Steady-state levels of ATXN3 protein are maintained."
      ],
      "specific_effects": [
        "The interaction is mediated by the Ubiquitin-binding site 2 (UbS2) on ATXN3.",
        "Binding of RAD23B to UbS2 impedes the ubiquitination-independent proteasomal degradation of ATXN3."
      ],
      "evidence": [
        {
          "paper_title": "Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23",
          "journal": "Nature Communications",
          "year": 2014,
          "relevant_quote": "Ataxin-3 interacts with the proteasome-associated proteins Rad23A/B through UbS2. Knockdown of Rad23 in cultured cells and in Drosophila results in lower levels of ataxin-3 protein.",
          "pmid": "25144244"
        }
      ],
      "pathway": {
        "name": "Ubiquitin-Proteasome System",
        "canonical_name": "Ubiquitin-Proteasome System",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "25144244"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    },
    {
      "function": "Protein Phase Separation",
      "arrow": "inhibits",
      "cellular_process": "ATXN3 is capable of undergoing liquid-liquid phase separation (LLPS), forming protein-rich droplets that can mature into solid, amyloid-like fibrillar aggregates, a hallmark of polyglutamine diseases. RAD23B, a key component of proteasomal condensates, directly interacts with ATXN3.",
      "effect_description": "Through heterotypic interactions, RAD23B inhibits the maturation or 'aging' of ATXN3 liquid droplets. This interaction delays the liquid-to-solid phase transition, thereby preventing the rapid formation of pathological, solid ATXN3 aggregates.",
      "biological_consequence": [
        "ATXN3 undergoes liquid-liquid phase separation to form droplets → RAD23B interacts with ATXN3 within these condensates → The interaction with RAD23B delays the maturation of ATXN3 droplets → The transition to solid, amyloid-like aggregates is slowed."
      ],
      "specific_effects": [
        "RAD23B is a known interactor of ATXN3 that drives the formation of proteasomal condensates.",
        "Heterotypic interactions with RAD23B inhibit the maturation of ATXN3 droplets but do not prevent amyloid formation in dilute conditions."
      ],
      "evidence": [
        {
          "paper_title": "Rad23B Delays Ataxin-3 Liquid-to-solid Phase Transition Through Heterotypic Buffering",
          "journal": "Journal of Molecular Biology",
          "year": 2025,
          "relevant_quote": "Rad23B, the main constituent driving the formation of proteasomal condensates, is a known Ataxin-3 interactor. We found that heterotypic interactions with Rad23B inhibit Ataxin-3 droplet maturation but do not inhibit amyloid formation under dilute conditions, suggesting that Ataxin-3 aggregation via misfolding pathway is distinct from condensation pathway.",
          "pmid": "40684934"
        }
      ],
      "pathway": {
        "name": "Regulation of Protein Phase Separation",
        "canonical_name": "Regulation Of Protein Phase Separation",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "40684934"
      ],
      "interaction_effect": "inhibits",
      "interaction_direction": "primary_to_main",
      "function_effect": "inhibition"
    }
  ],
  "arrow": "regulates",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The input claim that ATXN3 'activates' proteasomal degradation via RAD23B is a contextual error and mechanistic opposite. The primary literature shows this interaction *prevents* ATXN3's own degradation. Furthermore, RAD23B has a specific role in regulating the material state of ATXN3.",
  "mechanism": "Similar to its homolog RAD23A, ATXN3 directly interacts with the proteasome shuttle protein RAD23B through its Ubiquitin-binding site 2 (UbS2). This binding event protects ATXN3 from proteasomal turnover. ATXN3 is capable of undergoing liquid-liquid phase separation (LLPS), forming protein-rich droplets that can mature into solid, amyloid-like fibrillar aggregates, a hallmark of polyglutamine diseases. RAD23B, a key component of proteasomal condensates, directly interacts with ATXN3.",
  "effect": "The interaction with RAD23B shields ATXN3 from degradation, thus increasing its stability and cellular protein levels. This function is considered redundant with RAD23A.; Through heterotypic interactions, RAD23B inhibits the maturation or 'aging' of ATXN3 liquid droplets. This interaction delays the liquid-to-solid phase transition, thereby preventing the rapid formation of pathological, solid ATXN3 aggregates.",
  "summary": "ATXN3 inhibits RAD23B to regulate inhibition of atxn3 proteasomal degradation and regulation of protein phase separation, ultimately affecting steady-state levels of atxn3 protein are maintained.",
  "evidence": [
    {
      "paper_title": "Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23",
      "journal": "Nature Communications",
      "year": 2014,
      "relevant_quote": "Ataxin-3 interacts with the proteasome-associated proteins Rad23A/B through UbS2. Knockdown of Rad23 in cultured cells and in Drosophila results in lower levels of ataxin-3 protein."
    },
    {
      "paper_title": "Rad23B Delays Ataxin-3 Liquid-to-solid Phase Transition Through Heterotypic Buffering",
      "journal": "Journal of Molecular Biology",
      "year": 2025,
      "relevant_quote": "Rad23B, the main constituent driving the formation of proteasomal condensates, is a known Ataxin-3 interactor. We found that heterotypic interactions with Rad23B inhibit Ataxin-3 droplet maturation but do not inhibit amyloid formation under dilute conditions, suggesting that Ataxin-3 aggregation via misfolding pathway is distinct from condensation pathway."
    }
  ],
  "pathways": [
    {
      "name": "Ubiquitin-Proteasome System",
      "canonical_name": "Ubiquitin-Proteasome System",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    },
    {
      "name": "Regulation of Protein Phase Separation",
      "canonical_name": "Regulation Of Protein Phase Separation",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 4
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--regulates-- RAD23B:",
  "protein_a": "RAD23B",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-01T05:51:49.709932Z",
  "last_updated": "2025-12-01T05:51:49.709932Z"
}